FindTrial
Sign In

Usefullness of Levonorgestrel intrauterine system in the treatment of Heavy menstrual bleeding

Safety, efficacy, and acceptability of Levonorgestrel intrauterine system in the management of Abnormal uterine bleeding - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/068177
Enrollment
87
Registered
2024-05-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle

Interventions

None listed

Sponsors

AIIMS Guwahati
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Women diagnosed with AUB 2. HMB due to benign conditions like idiopathic HMB, fibroid not distorting uterine cavity, adenomyosis, Iatrogenic causes, coagulopathies

Exclusion criteria

Exclusion criteria: 1. Active genital tract infection 2. Severe anaemia 3. Pregnancy 4. Patients who are planning pregnancy

Design outcomes

Primary

MeasureTime frame
Efficacy of LNG IUS in decreasing menstrual blood loss by using PBAC chartTimepoint: 1, 3, 6 months—

Secondary

MeasureTime frame
Acceptibility of LNG IUS using Likert scale.Timepoint: 1, 3, 6 months;Improvement in Haemoglobin levelsTimepoint: 1, 3, 6 months—

Countries

India

Contacts

Public ContactHimangshu Malakar

AIIMS Guwahati

himangshumalakar@aiimsguwahati.ac.in9854609022

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026